Patents by Inventor Bernd Colin Eichenmueller

Bernd Colin Eichenmueller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of reducing virucidal activity in PCV-2 compositions and PCV-2 compositions with an improved immunogenicity
    Patent number: 9561270
    Abstract: The present invention provides methods of reducing the virucidal activity of a composition comprising a PCV-2 antigen as well as antigenic preparations and immunogenic compositions comprising a PCV-2 antigen, wherein the virucidal activity has been reduced. In addition, the present invention also relates to a method of increasing the immunogenicity of an immunogenic composition comprising a PCV-2 antigen as well as immunogenic composition with an increased immunogenicity.
    Type: Grant
    Filed: September 2, 2010
    Date of Patent: February 7, 2017
    Assignee: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Caroline Ann Kohler, Guosong Zhao, Ali Khazraeinazmpour, Bernd Colin Eichenmueller, Marc Allan Eichmeyer, Gregory Haiwick, Merrill Lynn Schaeffer
  • METHODS OF REDUCING VIRUCIDAL ACTIVITY IN PCV-2 COMPOSITIONS AND PCV-2 COMPOSITIONS WITH AN IMPROVED IMMUNOGENICITY
    Publication number: 20110059126
    Abstract: The present invention provides methods of reducing the vircidal activity of a composition comprising a PCV-2 antigen as well as antigenic preparations and immunogenic compositions comprising a PCV-2 antigen, wherein the virucidal activity has been reduced. In addition, the present invention also relates to a method of increasing the immunogenicity of an immunogenic composition comprising a PCV-2 antigen as well as immunogenic composition with an increased immunogenicity.
    Type: Application
    Filed: September 2, 2010
    Publication date: March 10, 2011
    Applicant: Boehringer Ingelheim Vetmedica, Inc.
    Inventors: Caroline Ann Kohler, Guosong Zhao, Ali Khazraeinazmpour, Bernd Colin Eichenmueller, Marc Allan Eichmeyer, Gregory Haiwick, Merrill Lynn Schaeffer